共 50 条
- [3] Comparison of two TSH-receptor antibody assays in graves' disease [J]. CLINICA CHIMICA ACTA, 2022, 530 : S285 - S286
- [5] High cut-off value of a chimeric TSH receptor (Mc4)-based bioassay may improve prediction of relapse in Graves’ disease for 12 months [J]. Endocrine, 2015, 48 : 89 - 95
- [10] Comparison of Five TSH-Receptor Antibody Assays in Graves’ disease: results from an observational pilot study [J]. BMC Endocrine Disorders, 19